Our study unveils novel insights into the potential roles of TP53 (tumor protein p53) and BCL6 (B-cell CLL/lymphoma 6) in ME/CFS pathogenesis (153, 154). This evidence concerns the gene BCL6 and myalgic encephalomeyelitis/chronic fatigue syndrome.